{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:05:03Z","timestamp":1793037903041,"version":"4.5.0"},"reference-count":116,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273539"],"award-info":[{"award-number":["82273539"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Histone deacetylase 6 (HDAC6) is a class IIb histone deacetylase that contains two catalytic domains and a zinc finger ubiquitin binding domain (ZnF-UBP). The deacetylation function of HDAC6 has been extensively studied with well-characterized substrates such as \u03b1-tubulin and Hsp90. Apart from its deacetylase activity, HDAC6 ZnF-UBP binds to unanchored ubiquitin of specific sequences and serves as a carrier for transport of aggregated proteins. subsequently, aggresomes is degraded by the autophagy-lysosome pathway. Additionally, Cells can utilize this HDAC6-dependent microtubule transport to assemble and activate inflammasomes, which play a critical role in immune regulation. HDAC6 displays a unique structure and cellular localization as well as diverse substrates, and exhibits a wider range of biological functions than other HDAC isoforms. HDAC6 has been intimately linked to a spectrum of diseases, including rheumatoid arthritis, systemic lupus erythematosus, psoriasis, neuritis, and the cancer immune microenvironment. This review systematically synthesizes the current research advancements of HDAC6, focusing on three key dimensions: the mechanism of action of HDAC6, therapeutic advancements, and translational prospects in clinical applications.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1653588","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:30:04Z","timestamp":1758519004000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["The regulatory mechanisms and treatment of HDAC6 in immune dysregulation diseases"],"prefix":"10.3389","volume":"16","author":[{"given":"Yanyang","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34974","article-title":"Recent histone deacetylase inhibitors in cancer therapy","volume":"129","author":"Parveen","year":"2023","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"8377","DOI":"10.1038\/s41467-024-52729-0","article-title":"Metabolic regulation of cytoskeleton functions by hdac6-catalyzed \u0391tubulin lactylation","volume":"15","author":"Sun","year":"2024","journal-title":"Nat Commun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2018.10.001","article-title":"Beyond histone acetylation-writing and erasing histone acylations","volume":"53","author":"Zhao","year":"2018","journal-title":"Curr Opin Struct Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (Hdacs): characterization of the classical hdac family","volume":"370","author":"Ruijter","year":"2003","journal-title":"Biochem J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114438","article-title":"New insights into the non-enzymatic function of hdac6","volume":"161","author":"Zhu","year":"2023","journal-title":"Biomedicine pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179592","article-title":"Targeting hdac6 to overcome autophagy-promoted anti-cancer drug resistance","volume":"23","author":"Jo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01782","article-title":"A review of progress in histone deacetylase 6 inhibitors research: structural specificity and functional diversity","volume":"64","author":"Zhang","year":"2021","journal-title":"J medicinal Chem"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.9b00934","article-title":"Structural basis of catalysis and inhibition of hdac6 cd1, the enigmatic catalytic domain of histone deacetylase 6","volume":"58","author":"Osko","year":"2019","journal-title":"Biochemistry"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat Chem Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molcel.2014.04.028","article-title":"Hdac6 deacetylates and ubiquitinates msh2 to maintain proper levels of muts\u03b1","volume":"55","author":"Zhang","year":"2014","journal-title":"Mol Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1042\/bcj20160172","article-title":"The growing landscape of tubulin acetylation: lysine 40 and many more","volume":"473","author":"Sadoul","year":"2016","journal-title":"Biochem J"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/875824","article-title":"The role of hdac6 in cancer","volume":"2011","author":"Aldana-Masangkay","year":"2011","journal-title":"J biomedicine Biotechnol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molcel.2007.05.033","article-title":"Hdac6 modulates cell motility by altering the acetylation level of cortactin","volume":"27","author":"Zhang","year":"2007","journal-title":"Mol Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"ra45","DOI":"10.1126\/scisignal.2002873","article-title":"Histone deacetylases 6 and 9 and sirtuin-1 control foxp3+ Regulatory T cell function through shared and isoform-specific mechanisms","volume":"5","author":"Beier","year":"2012","journal-title":"Sci Signaling"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2015.12.012","article-title":"Essential role of hdac6 in the regulation of pd-L1 in melanoma","volume":"10","author":"Lienlafa","year":"2016","journal-title":"Mol Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2017.01.025","article-title":"A novel hdac6 inhibitor tubastatin A: controls hdac6-P97\/vcp-mediated ubiquitination-autophagy turnover and reverses temozolomide-induced er stress-tolerance in gbm cells","volume":"391","author":"Li","year":"2017","journal-title":"Cancer Lett"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.273730","article-title":"Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini","volume":"287","author":"Ouyang","year":"2012","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.627950","article-title":"Chaperone-mediated 26s proteasome remodeling facilitates free K63 ubiquitin chain production and aggresome clearance","volume":"290","author":"Nanduri","year":"2015","journal-title":"J Biol Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.081232","article-title":"P62\/sqstm1 in autophagic clearance of a non-ubiquitylated substrate","volume":"124","author":"Watanabe","year":"2011","journal-title":"J Cell Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s10020-021-00375-3","article-title":"Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90","volume":"27","author":"Liu","year":"2021","journal-title":"Mol Med (Cambridge Mass)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C500186200","article-title":"Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: A novel basis for antileukemia activity of histone deacetylase inhibitors","volume":"280","author":"Bali","year":"2005","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/prot.10101","article-title":"Interaction of hsp90 with 20s proteasome: thermodynamic and kinetic characterization","volume":"48","author":"Eleuteri","year":"2002","journal-title":"Proteins"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160667","article-title":"Pharmacologic inhibition of hsp90 to prevent glt-1 degradation as an effective therapy for epilepsy","volume":"214","author":"Sha","year":"2017","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41419-018-0688-5","article-title":"The novel histone de acetylase 6 inhibitor, mpt0g211, ameliorates tau phosphorylation and cognitive deficits in an alzheimer\u2019s disease model","volume":"9","author":"Fan","year":"2018","journal-title":"Cell Death Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.763831","article-title":"The role of hdac6 in autophagy and nlrp3 inflammasome","volume":"12","author":"Chang","year":"2021","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp3687","article-title":"The hdac6 inhibitor avs100 (Ss208) induces a pro-inflammatory tumor microenvironment and potentiates immunotherapy","volume":"10","author":"Kovalovsky","year":"2024","journal-title":"Sci Adv"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/science.aas8995","article-title":"Hdac6 mediates an aggresome-like mechanism for nlrp3 and pyrin inflammasome activation","volume":"369","author":"Magupalli","year":"2020","journal-title":"Sci (New York NY)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.675724","article-title":"Inhibition of hdac6 activity protects against endothelial dysfunction and atherogenesis in vivo: A role for hdac6 neddylation","volume":"12","author":"Nomura","year":"2021","journal-title":"Front Physiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"22550","DOI":"10.1038\/s41598-022-27230-7","article-title":"Histone deacetylase 6 plays an important role in tgf-\u0392-induced murine treg cell differentiation by regulating cell proliferation","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13075-017-1357-2","article-title":"Therapeutic effect of a novel histone deacetylase 6 inhibitor, ckd-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro","volume":"19","author":"Oh","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clim.2015.11.007","article-title":"Specific hdac6 inhibition by acy-738 reduces sle pathogenesis in nzb\/W mice","volume":"162","author":"Regna","year":"2016","journal-title":"Clin Immunol (Orlando Fla)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.590072","article-title":"Hdac6 inhibition alleviates cll-induced T-cell dysfunction and enhances immune checkpoint blockade efficacy in the E\u03bc-tcl1 model","volume":"11","author":"Maharaj","year":"2020","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.11.017","article-title":"Acy-1215 exhibits anti-inflammatory and chondroprotective effects in human osteoarthritis chondrocytes via inhibition of stat3 and nf-\u039ab signaling pathways","volume":"109","author":"Cheng","year":"2019","journal-title":"Biomedicine pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109166","article-title":"Inhibition of hdac6 attenuates lps-induced inflammation in macrophages by regulating oxidative stress and suppressing the tlr4-mapk\/nf-\u039ab pathways","volume":"117","author":"Zhang","year":"2019","journal-title":"Biomedicine pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.03.017","article-title":"Hdac6 inhibition blocks inflammatory signaling and caspase-1 activation in lps-induced acute lung injury","volume":"370","author":"Liu","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"New Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.686155","article-title":"Promising therapeutic targets for treatment of rheumatoid arthritis","volume":"12","author":"Huang","year":"2021","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1383663","article-title":"Novel mechanistic study of hdac6 regulation of rheumatoid arthritis via cma: exploring potential therapeutic targets","volume":"15","author":"Lin","year":"2024","journal-title":"Front Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-209064","article-title":"Histone deacetylase 3 regulates the inflammatory gene expression program of rheumatoid arthritis fibroblast-like synoviocytes","volume":"76","author":"Angiolilli","year":"2017","journal-title":"Ann rheumatic Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2011.00058","article-title":"Inhibition of hdac activity by itf2357 ameliorates joint inflammation and prevents cartilage and bone destruction in experimental arthritis","volume":"17","author":"Joosten","year":"2011","journal-title":"Mol Med (Cambridge Mass)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.12501","article-title":"A novel histone deacetylase 6-selective inhibitor suppresses synovial inflammation and joint destruction in a collagen antibody-induced arthritis mouse model","volume":"18","author":"Lee","year":"2015","journal-title":"Int J rheumatic Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"17297","DOI":"10.1038\/s41598-018-35602-1","article-title":"Ckd-506, a novel hdac6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus","volume":"8","author":"Choi","year":"2018","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz317","article-title":"Novel histone deacetylase 6 inhibitor ckd-506 inhibits nf-\u039ab signaling in intestinal epithelial cells and macrophages and ameliorates acute and chronic murine colitis","volume":"26","author":"Lee","year":"2020","journal-title":"Inflammatory bowel Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13075-020-02258-0","article-title":"Therapeutic potential of ckd-506, a novel selective histone deacetylase 6 inhibitor, in a murine model of rheumatoid arthritis","volume":"22","author":"Park","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"B46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s43440-020-00188-x","article-title":"M-134, a novel hdac6-selective inhibitor, markedly improved arthritic severity in a rodent model of rheumatoid arthritis when combined with tofacitinib","volume":"73","author":"Bae","year":"2021","journal-title":"Pharmacol reports: PR"},{"key":"B47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13075-021-02561-4","article-title":"Inhibition of histone deacetylase 6 suppresses inflammatory responses and invasiveness of fibroblast-like-synoviocytes in inflammatory arthritis","volume":"23","author":"Park","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1602235","article-title":"Immune metabolic restoration in systemic lupus erythematosus: the impact of gut microbiota, probiotics, and nutritional synergy","volume":"16","author":"Habiballah","year":"2025","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","article-title":"Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics","volume":"10","author":"Dai","year":"2025","journal-title":"Signal transduction targeted Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102736","article-title":"B cell activating factor (Baff): structure, functions, autoimmunity and clinical implications in systemic lupus erythematosus (Sle)","volume":"20","author":"M\u00f6ckel","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102870","article-title":"Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies","volume":"132","author":"Li","year":"2022","journal-title":"J Autoimmun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01027","article-title":"T cell metabolism: A new perspective on th17\/treg cell imbalance in systemic lupus erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02512","article-title":"Selective histone deacetylase 6 inhibition normalizes B cell activation and germinal center formation in a model of systemic lupus erythematosus","volume":"10","author":"Ren","year":"2019","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7168935","article-title":"The association of complements, tgf-\u0392, and il-6 with disease activity, renal damage, and hematological activity in patients with na\u00efve sle","volume":"2022","author":"Yuliasih","year":"2022","journal-title":"Int J Inflammation"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet (London England)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.339","article-title":"Identification, Psoriasis Mo, et\u00a0al. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12465","article-title":"Comorbidities and health-related quality of life in spanish patients with moderate to severe psoriasis: A cross-sectional study (Arizona study)","volume":"41","author":"Sanchez-Carazo","year":"2014","journal-title":"J Dermatol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"B60","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling pathways and targeted therapies for psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal transduction targeted Ther"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nature05913","article-title":"Perceptions of epigenetics","volume":"447","author":"Bird","year":"2007","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.852272","article-title":"Role of histone post-translational modifications in inflammatory diseases","volume":"13","author":"Lin","year":"2022","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c02883","article-title":"Development of hydrazide-based hdac6 selective inhibitors for treating nlrp3 inflammasome-related diseases","volume":"68","author":"Yue","year":"2025","journal-title":"J medicinal Chem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11050336","article-title":"Selective targeting of epigenetic readers and histone deacetylases in autoimmune and inflammatory diseases: recent advances and future perspectives","volume":"11","author":"Ghiboub","year":"2021","journal-title":"J personalized Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/life10090157","article-title":"Histone deacetylase 1 and sirtuin 1 expression in psoriatic skin: A comparison between guttate and plaque psoriasis","volume":"10","author":"Hwang","year":"2020","journal-title":"Life (Basel Switzerland)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914551","article-title":"Histone and histone acetylation-related alterations of gene expression in uninvolved psoriatic skin and their effects on cell proliferation, differentiation, and immune responses","volume":"24","author":"Romh\u00e1nyi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2212-y","article-title":"Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation","volume":"11","author":"Thatikonda","year":"2020","journal-title":"Cell Death Dis"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.25011\/cim.v35i6.19205","article-title":"Vascular endothelial growth factor production is induced by histone deacetylase 1 and suppressed by von hippel-lindau protein in hacat cells","volume":"35","author":"Reynoso-Rold\u00e1n","year":"2012","journal-title":"Clin Invest Med Medecine clinique experimentale"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c01681","article-title":"Discovery of janus kinase and histone deacetylase dual inhibitors as a new strategy to treat psoriasis","volume":"67","author":"Hu","year":"2024","journal-title":"J medicinal Chem"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-21-0238","article-title":"Preclinical development and first-in-human study of ka2507, a selective and potent inhibitor of histone deacetylase 6, for patients with refractory solid tumors","volume":"27","author":"Tsimberidou","year":"2021","journal-title":"Clin Cancer research: an Off J Am Assoc Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13045-018-0654-9","article-title":"Histone deacetylase 6 in cancer","volume":"11","author":"Li","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-021-01359-x","article-title":"Acy-241, an hdac6 inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by inducing autophagy","volume":"44","author":"Park","year":"2021","journal-title":"Arch pharmacal Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.907981","article-title":"Role of selective histone deacetylase 6 inhibitor acy-1215 in cancer and other human diseases","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA: Cancer J Clin"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clcc.2011.05.005","article-title":"An update on the current and emerging targeted agents in metastatic colorectal cancer","volume":"11","author":"Chu","year":"2012","journal-title":"Clin colorectal Cancer"},{"key":"B76","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13045-022-01294-4","article-title":"Exploring immunotherapy in colorectal cancer","volume":"15","author":"Weng","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to pd-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Sci (New York NY)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2201408","article-title":"Discovery of novel benzohydroxamate-based histone deacetylase 6 (Hdac6) inhibitors with the ability to potentiate anti-pd-L1 immunotherapy in melanoma","volume":"38","author":"Peng","year":"2023","journal-title":"J Enzyme inhibition medicinal Chem"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03624-y","article-title":"Hdac6 inhibitor acy-1215 enhances stat1 acetylation to block pd-L1 for colorectal cancer immunotherapy","volume":"73","author":"Wen","year":"2024","journal-title":"Cancer immunology immunotherapy: CII"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00567","article-title":"Rational design of suprastat: A novel selective histone deacetylase 6 inhibitor with the ability to potentiate immunotherapy in melanoma models","volume":"63","author":"NooNepalle","year":"2020","journal-title":"J medicinal Chem"},{"key":"B81","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40425-019-0517-0","article-title":"Hdac6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics","volume":"7","author":"Laino","year":"2019","journal-title":"J immunotherapy Cancer"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007588","article-title":"Dual molecule targeting hdac6 leads to intratumoral cd4+ Cytotoxic lymphocytes recruitment through mhc-ii upregulation on lung cancer cells","volume":"12","author":"Ducellier","year":"2024","journal-title":"J immunotherapy Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41698-025-00949-y","article-title":"Hdac6 facilitates luad progression by inducing emt and enhancing macrophage polarization towards the M2 phenotype","volume":"9","author":"Jiang","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S509316","article-title":"Hdac1 mediates immunosuppression of the tumor microenvironment in non-small cell lung cancer","volume":"18","author":"Fan","year":"2025","journal-title":"J Inflammation Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.Crc-23-0528","article-title":"Hdac6 inhibition releases hr23b to activate proteasomes, expand the tumor immunopeptidome and amplify T-cell antimyeloma activity","volume":"4","author":"Rana","year":"2024","journal-title":"Cancer Res Commun"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav9518","article-title":"Amyloid \u0392 Oligomers constrict human capillaries in alzheimer\u2019s disease via signaling to pericytes","volume":"365","author":"Nortley","year":"2019","journal-title":"Sci (New York NY)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2015.10.019","article-title":"Soluble A\u0392 Oligomers impair hippocampal ltp by disrupting glutamatergic\/gabaergic balance","volume":"85","author":"Lei","year":"2016","journal-title":"Neurobiol Dis"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.04.035","article-title":"Tau kinetics in neurons and the human central nervous system","volume":"98","author":"Sato","year":"2018","journal-title":"Neuron"},{"key":"B89","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1038\/s41467-020-19317-4","article-title":"An hdac6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline","volume":"11","author":"Trzeciakiewicz","year":"2020","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40478-018-0604-3","article-title":"Pharmacological inhibition of hdac6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment","volume":"6","author":"Ma","year":"2018","journal-title":"Acta neuropathologica Commun"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115327","article-title":"Design, synthesis, and anti-inflammatory activity characterization of novel brain-permeable hdac6 inhibitors","volume":"254","author":"Liu","year":"2023","journal-title":"Eur J medicinal Chem"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.10.040","article-title":"Recent advances in the discovery of potent and selective hdac6 inhibitors","volume":"143","author":"Wang","year":"2018","journal-title":"Eur J medicinal Chem"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304545","article-title":"Structure-based discovery of a small molecule inhibitor of histone deacetylase 6 (Hdac6) that significantly reduces alzheimer\u2019s disease neuropathology","volume":"11","author":"Mondal","year":"2024","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13081","article-title":"Acetylation changes tau interactome to degrade tau in alzheimer\u2019s disease animal and organoid models","volume":"19","author":"Choi","year":"2020","journal-title":"Aging Cell"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0234-4","article-title":"Molecular and functional signatures in a novel alzheimer\u2019s disease mouse model assessed by quantitative proteomics","volume":"13","author":"Kim","year":"2018","journal-title":"Mol neurodegeneration"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010818-021524","article-title":"Neuropathic pain: mechanism-based therapeutics","volume":"60","author":"Bannister","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol Rev"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.20.2433","article-title":"Depression and pain comorbidity: A literature review","volume":"163","author":"Bair","year":"2003","journal-title":"Arch Internal Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00346","article-title":"Normalizing hdac2 levels in the spinal cord alleviates thermal and mechanical hyperalgesia after peripheral nerve injury and promotes gad65 and kcc2 expression","volume":"13","author":"Ouyang","year":"2019","journal-title":"Front Neurosci"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2018.09.029","article-title":"Expression of acetyl-histone H3 and acetyl-histone H4 in dorsal root ganglion and spinal dorsal horn in rat chronic pain models","volume":"211","author":"Liang","year":"2018","journal-title":"Life Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2016.06.019","article-title":"Histone deacetylase 3 (Hdac 3) as emerging drug target in nf-\u039ab-mediated inflammation","volume":"33","author":"Leus","year":"2016","journal-title":"Curr Opin Chem Biol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11040732","article-title":"Sp1 S-sulfhydration induced by hydrogen sulfide inhibits inflammation via hdac6\/myd88\/nf-\u039ab signaling pathway in adjuvant-induced arthritis","volume":"11","author":"Li","year":"2022","journal-title":"Antioxidants (Basel Switzerland)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.109803","article-title":"Hdac6 inhibitor acy-1215 improves neuropathic pain and its comorbidities in rats of peripheral nerve injury by regulating neuroinflammation","volume":"353","author":"Chen","year":"2022","journal-title":"Chemico-biological Interact"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.3c02006","article-title":"Design and synthesis of dual-targeting inhibitors of seh and hdac6 for the treatment of neuropathic pain and lipopolysaccharide-induced mortality","volume":"67","author":"Chen","year":"2024","journal-title":"J medicinal Chem"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21204","article-title":"Chemotherapy-induced peripheral neurotoxicity: A critical analysis","volume":"63","author":"Park","year":"2013","journal-title":"CA: Cancer J Clin"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000893","article-title":"Hdac6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy","volume":"158","author":"Krukowski","year":"2017","journal-title":"Pain"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001667","article-title":"Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers","volume":"160","author":"Ma","year":"2019","journal-title":"Pain"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123219","article-title":"Curriculum vitae of hdac6 in solid tumors","volume":"230","author":"Zheng","year":"2023","journal-title":"Int J Biol macromolecules"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4405","article-title":"The hdac6 inhibitor acy\u22121215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells","volume":"53","author":"Lee","year":"2018","journal-title":"Int J Oncol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41419-018-0788-2","article-title":"Ricolinostat (Acy-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via mir-30d\/pi3k\/akt\/mtor and erk pathways","volume":"9","author":"Cao","year":"2018","journal-title":"Cell Death Dis"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186873","article-title":"Combination of acy-241 and jq1 synergistically suppresses metastasis of hnscc via regulation of mmp-2 and mmp-9","volume":"21","author":"Cho","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.322","article-title":"Combination of a novel hdac6 inhibitor acy-241 and anti-pd-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma","volume":"32","author":"Ray","year":"2018","journal-title":"Leukemia"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.2174\/1389557516666160428115959","article-title":"Beyond the selective inhibition of histone deacetylase 6","volume":"16","author":"Rodrigues","year":"2016","journal-title":"Mini Rev medicinal Chem"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01444","article-title":"Controlling plasma stability of hydroxamic acids: A medchem toolbox","volume":"60","author":"Hermant","year":"2017","journal-title":"J medicinal Chem"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.3c00801","article-title":"Chemical versatility in catalysis and inhibition of the class iib histone deacetylases","volume":"57","author":"Christianson","year":"2024","journal-title":"Accounts Chem Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1653588\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:30:05Z","timestamp":1758519005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1653588\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":116,"alternative-id":["10.3389\/fimmu.2025.1653588"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1653588","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"article-number":"1653588"}}